% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

  • dnb2020 dnb2020 Apr 18, 2013 1:09 PM Flag

    This would be an interesting outcome for shorts to get trapped! Can DVAX ask for a hearing or submit new data?

    John Jenkins, M.D., director of CDER's Office of New Drugs, says, "It's often a combination of problems that prevent approval." Close communication with the FDA early on in a drug's development reduces the chance that an application will have to go through more than one cycle of review, he says. "But it's no guarantee."

    The FDA outlines the justification for its decision in a complete response letter to the drug sponsor and CDER gives the sponsor a chance to meet with agency officials to discuss the deficiencies. At that point, the sponsor can ask for a hearing, correct any deficiencies and submit new information, or withdraw the application

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think the delay in DVAX announcing the FDA meeting is because they are working thorugh a very detailed complex solution that works....not holding back bad news and worrying about the stock price....for example didn't the advisory committee notes say that they would have approved DVAX for limited use but they applied for the widespread use?.....why does DVAX need to reapply then? Just provide the other studies to FDA and bring in the advisory committee vote count for that use......the only drawback to this argument is that FDA is a government agency and inherently beaurucratic.....but they are less so than other govt agencies....I am upgrading DVAX to a buy since I think they get some limited approval now without further studies and reapplying....they pull a rabbit out of the hat on everyone...imho

      Sentiment: Buy

      • 1 Reply to dnb2020
      • dnb, I have been a bull on this stock, however I am now a Bear. Did you see the shareholder notice for the gigantic dilution. "Protect against hostile takeover..." my #$%$.

        Dynavax would never hold bad news would they? How about Feb 22nd?

        If it sounds like sour grapes, it is. This company takes 2 and a half steps forward, and two steps back. I question the value of staying in this.

        For a short term buy and hold in the Fall maybe there's some value, but staying in it now, it is hard for me to justify.

15.85-0.25(-1.55%)May 26 4:00 PMEDT